Device Sectors
Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business
July 9, 2010 10:39 am | by Bio-Medicine.Org | News | CommentsRALEIGH, N.C. , July 9 /- Pioneer Surgical Technology, Inc. recently expanded its Biologics Product Specialist program to provide sales and technical biologic expertise to support their growing line of products that address bone and soft tissue repair. Mr. Shane Ray , General Manager for...
Stereotaxis Announces Second Quarter 2010 Earnings Release Date and Conference Call
July 9, 2010 10:37 am | by Bio-Medicine.Org | News | CommentsST. LOUIS , July 9 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that it will release its financial results for the second quarter ended June 30, 2010 , on Monday, August 2, 2010 after the close of the market. The Company will host a conference call and webcast on Monday, August 2,...
New UC Davis study finds early Alzheimer's identification method
July 9, 2010 10:34 am | by EurekAlert | News | Comments(University of California - Davis - Health System) Abnormal brain images combined with examination of the composition of the fluid that surrounds the spine may offer the earliest signs identifying healthy older adults at risk of developing Alzheimer's disease, well before cognitive...
Preliminary highlights of the AAPM 52nd Annual Meeting, Philadelphia, Pa., July 18-22, 2010
July 9, 2010 10:34 am | by EurekAlert | News | Comments(American Institute of Physics) At the 52nd meeting of the American Association of Physicists in Medicine, which convenes from July 18-22, 2010 in Philadelphia, Pa., thousands of scientists and board-certified health professionals will gather to share the latest developments in...
Drug Study Shows Improvement in Major Orthopedic Surgery Care
July 9, 2010 5:36 am | by Bio-Medicine.Org | News | CommentsHAMILTON , Canada , July 9, 2010 /- An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being led by a steering committee chaired by McMaster University...
Extremely obese children have 40 percent higher risk of reflux disease of esophagus
July 9, 2010 5:35 am | by EurekAlert | News | Comments(Kaiser Permanente) A study of 690,000 children found extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease and moderately obese children have a 30 percent higher risk of GERD compared to normal weight children.This large population-based study...
Pfizer Hemophilia presents new data at the World Federation of Hemophilia 2010 Congress
July 9, 2010 5:34 am | by EurekAlert | News | Comments(Edelman Public Relations) Pfizer today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia (WFH) 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical...
Instant testing for sore throats wins CIMIT prize
July 8, 2010 7:34 pm | by EurekAlert | News | Comments(CIMIT) Imagine finding out before you leave the pediatrician's office if your child has strep throat, or even something more serious requiring a different treatment. A novel application for applying DNA "nanobarcodes" in a clinical assay could help primary-care physicians quickly...
Reportlinker Adds 2010 U.S. Ophthalmologists' Assessment of Eye Care Medication Brands
July 8, 2010 1:37 pm | by Bio-Medicine.Org | News | CommentsNEW YORK , July 8 /- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0236247/2010-US-Ophthalmologists-Assessment... This study encompasses feedback provided by U.S. physicians on...
FDA Consumer Health Information: Using Malaria Medication For Leg Cramps Is Risky
July 8, 2010 1:37 pm | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md. , July 8 /PRNewswire-USNewswire/ -- People who use the malaria drug Qualaquin to treat or prevent nighttime leg cramps may want to talk to their health care professional. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:...
PEAK Surgical Introduces PEAK PlasmaBlade(R) 3.0S
July 8, 2010 10:37 am | by Bio-Medicine.Org | News | CommentsPALO ALTO, Calif. , July 8 /- PEAK Surgical, Inc. today announced the launch of the PEAK PlasmaBlade® 3.0S dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This revolutionary product features a 3.0mm wide blade for even greater cutting...
Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris
July 8, 2010 10:37 am | by Bio-Medicine.Org | News | CommentsPARIS , July 8, 2010 /- Professor Gerard Saillant , President of the Institute for Brain and Spinal Cord Disorders (ICM), announced today an unprecedented donation of EUR8,000,000 from Mrs. Lily Safra . It is the largest single donation made by a private individual to the ICM. Professor Saillant...
ECRI Institute Adds 4,000 New Terms to Universal Medical Device Nomenclature Systemâ„¢
July 8, 2010 10:35 am | by Bio-Medicine.Org | News | CommentsFree license gives access to 24,544 terms, including genetic testing and device software PLYMOUTH MEETING, Pa. , July 8 /PRNewswire-USNewswire/ -- ECRI Institute's Universal Medical Device Nomenclature System™, the most comprehensive medical device taxonomy, announces the...
Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
July 8, 2010 10:35 am | by Bio-Medicine.Org | News | CommentsALBUQUERQUE, N.M. , July 8 /- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP). The CAP is a leading...
US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others
July 8, 2010 5:37 am | by Bio-Medicine.Org | News | CommentsMINNEAPOLIS , July 8 /- Protectus Medical Devices, Inc. (OTCQB: PTMD), developer and marketer of innovative safety medical devices, announced today it has received Notice of Allowance from the US Patent and Trademark Office on its patent application describing a spring-activated,...
Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States
July 8, 2010 5:37 am | by Bio-Medicine.Org | News | CommentsAMSTERDAM , July 8 /- Biopharmaceutical Company Kiadis Pharma announced today that it has received approval for its Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to start the pivotal clinical study for its product ATIR™ in the United...
New Report Patient Monitoring Emerging Markets (BRIC - Brazil, Russia, India and China) 2010 - 2014 Published by MarketsandMarkets
July 8, 2010 5:36 am | by Bio-Medicine.Org | News | CommentsDALLAS , July 8, 2010 /- According to a new market research report, 'Emerging Markets BRIC ( Brazil , Russia , India and China ) Patient Monitoring Market (2010 - 2015), published by MarketsandMarkets ( http://www.marketsandmarkets.com ), the total BRIC patient monitoring devices market...
Simple diagnostic tool predicts Type 2 diabetes in Southeast Asians
July 8, 2010 5:35 am | by EurekAlert | News | Comments(Research Australia) Australian and Vietnamese researchers have estimated the current prevalence of Type 2 diabetes in Vietnam, and have developed a simple tool for identifying individuals at high risk.Often triggered by sedentary lifestyles and high-fat or high-sugar diets,...
Enrollment Underway in CLARITY-AF Study to Compare Efficacy, Safety and Efficiency of Two Catheter Ablation Technologies
July 8, 2010 5:35 am | by Bio-Medicine.Org | News | CommentsWATERLOO, Belgium , July 8, 2010 /- Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announces that more than 10 patients have now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the efficacy, safety and efficiency of CARTO(R)...
Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial
July 8, 2010 5:35 am | by Boston Scientific | News | CommentsNATICK, Mass., July 8 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced enrollment of the first patient in its MultiSENSE clinical trial. The trial is designed to evaluate multiple physiolog
Michael Garippa Joins SynCardia as President
July 8, 2010 12:34 am | by SynCardia | News | CommentsSynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Michael Garippa, the CEO and President of TandemHeart for the last 8 years, has left the company to become SynCardia's new president. Rodger Ford will continue as SynCardia's CEO,...
Home care equivalent to hospital care for some patients with cystic fibrosis
July 7, 2010 10:36 pm | by EurekAlert | News | Comments(American Thoracic Society) Patients with cystic fibrosis recover from exacerbations equally well if they are treated at home or in a hospital, according to researchers from Johns Hopkins University. Furthermore, longer treatment with antibiotics does not appear to offer any...
Multistep Diagnostics on Paper
July 7, 2010 10:35 pm | by Massachusetts Institute of Technology | News | CommentsA credit-card-sized diagnostic device can perform a task normally carried out by complex equipment.
Multiplying DNA One Drop at a Time
July 7, 2010 10:34 pm | by Massachusetts Institute of Technology | News | CommentsRainDance Technologies says its method of amplifying DNA in drops of water will expand clinical genetic testing.
Stryker to Host Conference Call on July 20, 2010
July 7, 2010 12:35 pm | by Bio-Medicine.Org | News | CommentsKALAMAZOO, Mich. , July 7 /- Stryker Corporation (NYSE: SYK ) announced that it will host a conference call on Tuesday, July 20, 2010 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended June 30, 2010 , and provide an operational update. Operating...
